Cellectis (NASDAQ:CLLS) Rating Increased to Buy at StockNews.com
StockNews.com upgraded shares of Cellectis (NASDAQ:CLLS – Free Report) from a hold rating to a buy rating in a research report report published on Monday morning. Cellectis Stock Performance Shares of NASDAQ:CLLS opened at $1.24 on Monday. The business’s 50-day simple moving average is $1.42 and its 200 day simple moving average is $1.73. The […]
StockNews.com upgraded shares of Cellectis (NASDAQ:CLLS – Free Report) from a hold rating to a buy rating in a research report report published on Monday morning. Cellectis Stock Performance Shares of NASDAQ:CLLS opened at $1.24 on Monday. The business’s 50-day simple moving average is $1.42 and its 200 day simple moving average is $1.73. The […]
